Axxess Pharma Analyst Coverage Continued: Research Report by Small Cap Street and BrokerBank Securities, Inc.

NEW YORK, Oct. 2, 2014 /PRNewswire/ -- Axxess Pharma, Inc. (OTCBB: AXXE) focuses on manufacturing and distributing various pharmaceutical and natural health products primarily in Canada and the United States. The Company has products that are approved and/or selling on the marketplace which reduces risks and expenses associated with extended clinical trials and regulatory approvals. The Company distributes through Health Canada through Websites, as well as retail locations in the United States to US military personnel. The company was formerly known as CGI Communications Services, Inc. and changed its name to Axxess Pharma, Inc. in July 2008. Axxess Pharma, Inc. was incorporated in 1997 and is headquartered in Toronto, Canada.

Large Available Market Opportunity – Markets for pharmaceuticals and OTC supplements are very large and remain fragmented. AXXE recently signed an expanded license agreement with Authentic Brands Group, LLC. to include several new, high-demand TapouT products. This expansion of TapouT's global license agreement was due to Axxess Pharma's successful marketing and sales of their current TapouT product line to the U.S. military, global distributors and retailers. The expanded license agreement is anticipated to significantly increase Axxess Pharma's world-wide sales in 2015 and 2016.

An analyst report which details the current situation, an overview of the company, products, financial analysis, technical chart analysis, risk factors, analyst comments and recommendation can be viewed in its entirety by using the link below. There is no cost obligation required to view this report: 

http://bit.ly/-AXXE--AnalystReport

Copy and paste may be required.

About Small Cap Street

Once you read our reports written by our team of financial analysts you will understand that we make every effort to provide informative equity research reports for interested parties at no cost.

Our Financial Analysts spend countless hours researching stocks. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges. These reports include a straightforward assessment of the company by a financial analyst who has pledged to remain free of influence when writing research reports.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. Information in this release is fact checked and produced on a best efforts basis by Michael Anderegg, a CFA charterholder. An outsourced research services provider represented by Michael Anderegg, CFA, provided Small Cap Street this article or report. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. Small Cap Street is not entitled to veto, interfere or alter the articles, documents or report once created and reviewed by the outsourced research provider represented by Michael Anderegg, CFA.

If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected]. For any urgent concerns or inquiries, please contact us at [email protected].

NOT FINANCIAL ADVICE

Small Cap Street and BrokerBank Securities, Inc. make no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Small Cap Street and BrokerBank Securities, Inc. are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. Small Cap Street has compensated Michael Anderegg, CFA, for the right to disseminate analyst report. No liability is accepted by Small Cap Street and BrokerBank Securities, Inc. whatsoever for any direct, indirect or consequential loss arising from the use of this document. Small Cap Street expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Small Cap Street and BrokerBank Securities, Inc. do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.

SOURCE Small Cap Street